<DOC>
	<DOCNO>NCT01942902</DOCNO>
	<brief_summary>The purpose study evaluate system performance GlySure Continuous Glucose Monitoring ( CGM ) system patient admit Surgical Intensive Care Unit .</brief_summary>
	<brief_title>A Comparative Study Evaluate Accuracy Safety GlySure Continuous Intravascular Glucose Monitoring System Versus Intermittent Blood Glucose Monitoring</brief_title>
	<detailed_description />
	<criteria>1 . Patient legal representative MUST willing sign inform consent document 2 . Male female age 18 year 3 . Require Central Venous Catheter ( CVC ) right internal Jugular vein part disease management treatment 4 . Expected remain Surgical Intensive Care Unit ( SICU ) least 30 hour 7 day 1 . Patient legal representative unable provide write informed consent 2 . Patient pregnant 3 . Patient currently administer Mannitol 4 . Patient history Pulmonary Embolism ( PE ) 5 . Patient history thrombosis 6 . Patient known hypercoagulation 7 . Patient known history heparin hypersensitivity 8 . Patient history heparin induce thrombocytopenia 9 . Participation clinical study involve unlicensed pharmaceutical product and/or device within 3 month prior enrolment study 10 . Patient known hypersensitivity/allergy adhesive I.V . dressing 3M Tegaderm film 11 . Patient likely require MRI scan stay SICU 12 . Patients likely require treatment Mannitol time SICU</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>